Now Reading: Molbio Diagnostics IPO opens with Rs 120 grey market premium
-
01
Molbio Diagnostics IPO opens with Rs 120 grey market premium
Molbio Diagnostics' initial public offering, which opened on August 10, is commanding a grey market premium of Rs 120 per share. This indicates a potential listing gain of about 14.87% over the…
The Story in Brief
Molbio Diagnostics' initial public offering, which opened on August 10, is commanding a grey market premium of Rs 120 per share. This indicates a potential listing gain of about 14.87% over the upper price band. The IPO, one of the most awaited in the diagnostics space, will close for subscription later this week. Analysts have mixed views about the valuation.
The Indian Opinion
For retail investors, the grey market premium is a double-edged sword. A 14.87% implied gain at listing looks tempting, but the GMP can swing wildly before the actual debut. Watch for the final subscription numbers and anchor investor quality instead of getting swayed by informal trades. A focused reading of the company's financials and peer comparison will separate signal from noise.
Source: ndtvprofit.com
This story was synthesised by AI from the source linked above.
